Peer-reviewed research published in JAMA Oncology validates the efficacy of MyProstateScore 2.0

FAQs

What is MyProstateScore 2.0 (MPS2)?

MPS2 is a urine test to help you better understand your risk of prostate cancer. The test measures 18 urine biomarkers to generate a report that predicts the percent likelihood that clinically significant prostate cancer is present.